AuthorCitation

Influence of molecular alterations on site-specific (ss) time to recurrence (TTR) following adjuvant therapy in resected colon cancer (CC) (Alliance Trial N0147).

Wilcox, Ryan Eldredge, Foster, Nathan R. , Meyers, Jeffrey P., Goldberg, Richard M. , Nair, Suresh , Shields, Anthony F. , Chan, Emily , Kahlenberg, Morton S., Shi, Qian , Sinicrope, Frank A. , Sargent, Daniel J. , Gill, Sharlene , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3590-3590

10.1200/jco.2015.33.15_suppl.3590

Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) receiving adjuvant chemotherapy: Results from NCCTG N0147 (Alliance).

Foster, Nathan R. , Grothey, Axel, Chan, Emily , Shields, Anthony F. , Goldberg, Richard M. , Kahlenberg, Morton S., Singh, Preet Paul , Shi, Qian , Nair, Suresh, Gill, Sharlene , Sinicrope, Frank A. , Sargent, Daniel J. , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3531-3531

10.1200/jco.2015.33.15_suppl.3531

Phase I, first-in-human trial of LV305 in patients with advanced or metastatic cancer expressing NY-ESO-1.

Somaiah, Neeta , Block, Matthew S. , Hwu, Patrick , Jones, Robin L. , Gnjatic, Sacha , Lu, Hailing , Hsu, Frank J., Gnjatic, Sacha , Jones, Robin L , Kim, Joseph W. , Shapiro, Geoffrey I. , Hwu, Patrick , Eder, Joseph P. , Pollack, Seth M.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3021-3021

10.1200/jco.2015.33.15_suppl.3021

Alcohol consumption and prognosis in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance).

Phipps, Amanda I. , Nelson, Garth D. , Chan, Emily , Goldberg, Richard M. , Kahlenberg, Morton S., Nair, Suresh , Shields, Anthony F. , Shi, Qian , Limburg, Paul J. , Sargent, Daniel J. , Sinicrope, Frank A. , Gill, Sharlene , Newcomb, Polly A. , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1508-1508

10.1200/jco.2015.33.15_suppl.1508

Comparison of HER2 gene amplification (AMP) in primary esophageal and gastroesophageal junction adenocarcinomas (EAC) and their metastatic regional lymph nodes (MLNs).

Yoon, Harry H. , Sukov, William R. , Sattler, Christopher A., Wiktor, Anne E., Diasio, Robert B. , Wu, Tsung‐Teh, Jenkins, Robert B. , Shi, Qian , Sinicrope, Frank A.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 4059-4059

10.1200/jco.2015.33.15_suppl.4059

Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX+/- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 tria

Thibodeau, Stephen N. , Mini, Enrico , Goldberg, Richard M. , Folprecht, Gunnar , Laethem, Jean‐Luc Van , Laurent‐Puig, Pierre , Laurent-Puig, Pierre , Taı̈eb, Julien , Malicot, Karine Le , Penault-Llorca, Frederique Madeleine , Bouché, Olivier , Shi, Qian , Tabernero, Josep , Sargent, Daniel J. , Alberts, Steven R. , Sinicrope, Frank A.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3507-3507

10.1200/jco.2015.33.15_suppl.3507

Analysis of DNA mismatch repair (MMR) and clinical outcome in stage III colon cancers from patients (pts) treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials.

Smyrk, Thomas C. , Julié, Catherine , Zawadi, Ayman, Mini, Enrico , Goldberg, Richard M. , Folprecht, Gunnar , Laethem, Jean‐Luc Van , Laurent‐Puig, Pierre , Laurent-Puig, Pierre , Zaanan, Aziz , Shi, Qian , Taı̈eb, Julien , Alberts, Steven R. , Tabernero, Josep , Malicot, Karine Le , Sargent, Daniel J. , Sinicrope, Frank A.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3506-3506

10.1200/jco.2015.33.15_suppl.3506

Subgroup analysis of patients enrolled in the United States in the CORRECT phase 3 trial of the multikinase inhibitor regorafenib (REG) in metastatic colorectal cancer (mCRC).

Kim, George P., Lenz, Heinz‐Josef , Verma, Udit, Saltzman, Marc, Fuloria, Jyotsna, Khojasteh, Ali , Wiesenfeld, Martin, Cihon, Frank, Wagner, Andrea, Grothey, Axel, Cutsem, Eric Van , Wagner, Andrea

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e14649-e14649

10.1200/jco.2015.33.15_suppl.e14649

Sustained exercise hyperemia during prolonged adenosine infusion in humans

Ranadive, Sushant M. , Shepherd, John R. A. , Curry, Timothy B. , Dinenno, Frank A. , Joyner, Michael J. , Ranadive, Sushant

Mayo Clinic

Physiological Reports | February 26, 2019 | Volume: 7 | Issue: 4 | Pages: e14009

10.14814/phy2.14009 | PMID 30806018

Fate of the Fontan connection: Mechanisms of stenosis and management

Hagler, Donald J. , Miranda, William R. , Haggerty, Brielle J., Johnson, Jonathan N. , Cetta, Frank , Said, Sameh M. , Taggart, Nathaniel W. , Anderson, Jason H. , Johnson, Jonathan , Taggart, Nathaniel W

Mayo Clinic

Congenital Heart Disease | February 26, 2019 | Volume: 14 | Issue: 4 | Pages: 571-581

10.1111/chd.12757 | PMID 30801968

Citations

Influence of molecular alterations on site-specific (ss) time to recurrence (TTR) following adjuvant therapy in resected colon cancer (CC) (Alliance Trial N0147).

Wilcox, Ryan Eldredge, Foster, Nathan R. , Meyers, Jeffrey P., Goldberg, Richard M. , Nair, Suresh , Shields, Anthony F. , Chan, Emily , Kahlenberg, Morton S., Shi, Qian , Sinicrope, Frank A. , Sargent, Daniel J. , Gill, Sharlene , Alberts, Steven R.

Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) receiving adjuvant chemotherapy: Results from NCCTG N0147 (Alliance).

Foster, Nathan R. , Grothey, Axel, Chan, Emily , Shields, Anthony F. , Goldberg, Richard M. , Kahlenberg, Morton S., Singh, Preet Paul , Shi, Qian , Nair, Suresh, Gill, Sharlene , Sinicrope, Frank A. , Sargent, Daniel J. , Alberts, Steven R.

Phase I, first-in-human trial of LV305 in patients with advanced or metastatic cancer expressing NY-ESO-1.

Somaiah, Neeta , Block, Matthew S. , Hwu, Patrick , Jones, Robin L. , Gnjatic, Sacha , Lu, Hailing , Hsu, Frank J., Gnjatic, Sacha , Jones, Robin L , Kim, Joseph W. , Shapiro, Geoffrey I. , Hwu, Patrick , Eder, Joseph P. , Pollack, Seth M.

Alcohol consumption and prognosis in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance).

Phipps, Amanda I. , Nelson, Garth D. , Chan, Emily , Goldberg, Richard M. , Kahlenberg, Morton S., Nair, Suresh , Shields, Anthony F. , Shi, Qian , Limburg, Paul J. , Sargent, Daniel J. , Sinicrope, Frank A. , Gill, Sharlene , Newcomb, Polly A. , Alberts, Steven R.

Comparison of HER2 gene amplification (AMP) in primary esophageal and gastroesophageal junction adenocarcinomas (EAC) and their metastatic regional lymph nodes (MLNs).

Yoon, Harry H. , Sukov, William R. , Sattler, Christopher A., Wiktor, Anne E., Diasio, Robert B. , Wu, Tsung‐Teh, Jenkins, Robert B. , Shi, Qian , Sinicrope, Frank A.

Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX+/- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 tria

Analysis of DNA mismatch repair (MMR) and clinical outcome in stage III colon cancers from patients (pts) treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials.

Subgroup analysis of patients enrolled in the United States in the CORRECT phase 3 trial of the multikinase inhibitor regorafenib (REG) in metastatic colorectal cancer (mCRC).

Kim, George P., Lenz, Heinz‐Josef , Verma, Udit, Saltzman, Marc, Fuloria, Jyotsna, Khojasteh, Ali , Wiesenfeld, Martin, Cihon, Frank, Wagner, Andrea, Grothey, Axel, Cutsem, Eric Van , Wagner, Andrea

Sustained exercise hyperemia during prolonged adenosine infusion in humans

Ranadive, Sushant M. , Shepherd, John R. A. , Curry, Timothy B. , Dinenno, Frank A. , Joyner, Michael J. , Ranadive, Sushant

Fate of the Fontan connection: Mechanisms of stenosis and management

Hagler, Donald J. , Miranda, William R. , Haggerty, Brielle J., Johnson, Jonathan N. , Cetta, Frank , Said, Sameh M. , Taggart, Nathaniel W. , Anderson, Jason H. , Johnson, Jonathan , Taggart, Nathaniel W